ITL increases production of medical devices during COVID-19 pandemic

21 January 2021 News

As a leader in contract design, development, and manufacturing of life-saving medical devices and in vitro diagnostic instruments, ITL is an essential link in the healthcare supply chain. Our manufacturing operations are nearing maximum capacity following an influx of new business and increased demand for existing customer orders.

We have increased output for manufacturing and delivery of instruments designed to improve respiratory function and oxygen uptake as part of a ventilator system for critical care patients, including those with coronavirus.  We have also had to rapidly scale up production to meet the demand for hygiene monitoring devices and rapid diagnostic testing platforms. The global market for medical, healthcare, and life science technology has soared since the outbreak of COVID-19, which has continued to highlight the growing pressure on overburdened healthcare systems worldwide, causing a surge of growth in the MedTech industry.

ITL has remained operational across all sites throughout the pandemic to ensure the supply of patient-critical medical equipment reaches the front-line – where needed most. We operate in line with advice from national and international governments and health authorities, and we continue to do everything we possibly can to ensure the health and safety of all employees.

Manufacturing processes and operations have been adapted where necessary to ensure safe working distances between employees who are required to report to work daily. All employees who can work remotely are now doing so and have been provided with the necessary technology and equipment needed to ensure key business functions can still perform critical tasks.

The efforts of ITL employees has never been more essential than right now. Our leadership team is doing its utmost to support all employees, key customers, and valued suppliers during these uncertain times.